Barrett & Company’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Barrett & Company's LLY Position: Q3 2026 in Review
Barrett & Company reduced its Eli Lilly (LLY) stake by 12% in Q3 2026, selling an estimated $144K and leaving 862 shares worth $998K. The position accounts for 0.27% of the portfolio, ranked #53.
Barrett & Company first reported a position in LLY in Q3 2022 and has held it in 17 quarters since. The position peaked at $1.18M in Q2 2026. 1,679 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Barrett & Company held 862 shares of Eli Lilly worth $998K as of Q3 2026.
- Barrett & Company sold 122 Eli Lilly shares in Q3 2026, an estimated $144K.
- Eli Lilly made up 0.27% of Barrett & Company's portfolio in Q3 2026, its #53 holding.
- Barrett & Company first reported a position in Eli Lilly in Q3 2022 and has held it in 17 quarters since.
- Barrett & Company's Eli Lilly position peaked at $1.18M in Q2 2026.
- 1,679 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Barrett & Company's 13F filing for Q3 2026, filed 22 Oct 2026.